President and CEO, Roivant Social Ventures
Lindsay Androski serves as President and CEO of Roivant Social Ventures. Ms. Androski joined Roivant Sciences as one of its earliest employees, and built and led the team responsible for the in-licensing or acquisition of more than 30 therapeutic programs, resulting in the launch and incubation of 16 subsidiary biotechs and several successful IPOs. Ms. Androski has likewise demonstrated a longstanding commitment to public service, including by serving on the MIT Alumni Association Board, as Chair of the MIT Annual Fund Board, on the Board of the Women Lawyers Association of LA, and on the Leadership Council of the LA Center for Law and Justice. Prior to joining Roivant Sciences, Ms. Androski spent more than a decade as a trial lawyer, including as an Assistant U.S. Attorney in Alexandria, Virginia, where she led investigations and prosecutions of high-profile cybercrime and national security cases and received the highest awards given by several federal agencies. Earlier in her career, Ms. Androski was a strategy consultant advising Fortune 100 clients on merger integration and other business challenges. Ms. Androski received two B.S. degrees from MIT, and J.D. and M.B.A degrees from The University of Chicago. She is a registered patent lawyer and a Chartered Financial Analyst.